Kronos Bio Inc (KRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2005 | 09-2004 | 09-2003 | 09-2002 | 09-2001 | |
| Sales | 518,658 | 450,694 | 397,355 | 342,377 | 295,290 |
| Cost of Goods | 200,038 | 176,068 | 157,139 | 133,090 | 112,801 |
| Gross Profit | 318,620 | 274,626 | 240,216 | 209,287 | 182,489 |
| Operating Expenses | 242,830 | 210,711 | 190,169 | 169,554 | 159,978 |
| Operating Income | 75,828 | 63,983 | 50,186 | 39,823 | 23,312 |
| Other Income | 5,710 | 5,619 | 4,375 | 4,668 | 2,079 |
| Pre-tax Income | 81,538 | 69,602 | 54,561 | 44,491 | 25,391 |
| Income Tax | 27,634 | 23,352 | 19,895 | 15,664 | 8,887 |
| Net Income Continuous | 53,904 | 46,250 | 34,666 | 28,827 | 16,504 |
| Net Income | $53,904 | $46,250 | $34,666 | $28,827 | $16,504 |
| EPS Basic Total Ops | 1.69 | 1.49 | 1.16 | 0.98 | 0.59 |
| EPS Basic Continuous Ops | 1.69 | 1.49 | 1.16 | 0.98 | 0.59 |
| EPS Diluted Total Ops | 1.65 | 1.44 | 1.12 | 0.94 | 0.57 |
| EPS Diluted Continuous Ops | 1.65 | 1.44 | 1.12 | 0.94 | 0.57 |
| EBITDA(a) | $109,132 | $92,589 | $76,347 | $61,817 | $47,480 |